Related Experiment Videos
Ischaemic heart-disease: possible genetic markers.
Lancet (London, England)
|October 11, 1975
Summary
Population frequencies of histocompatibility antigen HLA-8 are linked to higher ischemic heart disease death rates. This suggests a genetic predisposition to hypercholesterolemia and heart disease, supporting immunogenetic hypotheses for vascular conditions.
Area of Science:
- Immunogenetics
- Cardiovascular Epidemiology
- Human Genetics
Background:
- Ischemic heart disease (IHD) exhibits significant geographical variations in mortality.
- Population frequencies of specific human leukocyte antigen (HLA) alleles have been investigated for associations with various diseases.
- Hypercholesterolemia is a major risk factor for IHD.
Purpose of the Study:
- To investigate the correlation between population frequencies of histocompatibility antigen HLA-8 and national death rates from IHD.
- To explore the potential link between HLA-8 and serum-cholesterol levels.
- To examine the role of HLA-8 and other HLA antigens (e.g., W15) in explaining high IHD and cholesterol levels in Finland.
Main Methods:
- Correlation analysis between population frequencies of HLA-8 and national IHD mortality rates.
- Comparison of serum-cholesterol levels with HLA-8 frequencies.
- Analysis of specific HLA antigen frequencies (HLA-8, W15) in populations with high IHD and cholesterol levels.
Main Results:
- Significant positive correlation found between national IHD death rates and population frequencies of HLA-8 and the 1-8 haplotype.
- Serum-cholesterol levels showed a potential correlation with HLA-8 population frequencies.
- Exceptionally high IHD mortality and serum-cholesterol levels in Finland may be associated with the combined effects of HLA-8 and W15.
Conclusions:
- HLA-8, and possibly W15, may be genetically linked to predispositions for hypercholesterolemia and IHD.
- These findings lend support to immunogenetic hypotheses concerning the etiology of vascular diseases in humans.
- Further research is warranted to elucidate the specific genetic mechanisms linking HLA antigens to lipid metabolism and cardiovascular risk.